Melinta Therapeutics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Melinta Therapeutics, Inc. - overview
Established
2000
Location
Parsippany, NJ, US
Primary Industry
Biotechnology
About
Founded in 2000 and based in Connecticut, US, Melinta Therapeutics, Inc. , formerly known as Rib-X Pharmaceuticals Inc. , operates as a developer of novel small molecule antibiotics for the treatment of serious infections. The company also offers products that are also used for the treatment of serious hospital gram-negative infections.
Current Investors
Deerfield Management, Sanofi, Warburg Pincus
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.melinta.com
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
Melinta Therapeutics, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restructuring | Completed | Melinta Therapeutics, Inc. | - |
Displaying 1 - 1 of 1
Melinta Therapeutics, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.